CD8A and opsoclonus-myoclonus syndrome: Furthermore, we demonstrate a massive influx of activated CD8+ CTL in regressing mouse tumors as was also observed in two human neuroblastomas associated with Opsoclonus Myoclonus Syndrome (OMS).